Evidence map›Paper›PMID 41859172›Full record

ArticleFrontiers in medicine2026

Design and preliminary evaluation of a VR-based optokinetic stimuli system for vestibular rehabilitation: insights from clinical end users.

Korak Sarkar, Kathleen Delpy, Summer Skelton, Alec Slayden, Nicole R Villemarette-Pittman

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Korak SarkarOchsner Clinic Foundation, New Orleans, LA, United States.
Kathleen DelpyOchsner Clinic Foundation, New Orleans, LA, United States.
Summer SkeltonOchsner Clinic Foundation, New Orleans, LA, United States.
Alec SlaydenOchsner Clinic Foundation, New Orleans, LA, United States.
Nicole R Villemarette-PittmanOchsner Clinic Foundation, New Orleans, LA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vestibular therapy is essential for treating dizziness and balance disorders. There is growing evidence supporting the benefits of incorporating Virtual Reality (VR) into vestibular therapies. Objective: To gather feedback from neuro-rehabilitation specialists on an optokinetic virtual environment (OVE). Methods: An OVE modeled after the traditional optokinetic drum was developed for commercially available VR headsets and tested by practicing vestibular therapists. Participants completed a Likert-based survey and semi-structured interviews to assess their perceptions of the OVE. Qualitative data were analyzed thematically. Results: Ten therapists with an average of 9 years of clinical experience (range: 3-15 years) participated from October 2024 to March 2025. The likelihood of using the OVE in clinical practice was rated highly, with Likert scores ranging from 6 to10 (median = 9), where 10 indicated a high likelihood. Five key themes emerged for potential improvements: (1) Clinical Usability and Setup, (2) Control and Customization, (3) Immersive Design and Realism, (4) Output and Measurement Preferences, and (5) Implementation Barriers. Conclusion: Vestibular rehabilitation clinicians expressed strong interest in utilizing VR-based optokinetic stimuli. Feedback from this study will inform iterative, user-focused application improvements. Future studies will test the improved OVE with patients to evaluate tolerance, efficacy, and usability.

Indexed as

medical extended realityneurologyphysical therapyvestibularvirtual reality

Identifiers

PMID41859172
PMCPMC12995672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.